Adma Biologics (ADMA) Return on Equity [ROE] (2011 - 2026)
Adma Biologics (ADMA) reported Return on Equity [ROE] of 43.09% for Q3 2026, down 7.41 percentage points from 50.50% a year earlier but up 0.77 percentage points from the prior quarter.
Powered by 
Analysis
Adma Biologics (ADMA) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2025, Adma Biologics posted Return on Equity [ROE] of 35.56%, down 46.08 percentage points from FY2024.
- Return on Equity [ROE] has a five-year change of +169.45 percentage points (FY2020 to FY2025).
- By year, Return on Equity [ROE] came in at 81.65% in FY2024 (+101.31 pp), -19.67% in FY2023 (+25.30 pp), -44.96% in FY2022 (+17.28 pp) and -62.24% in FY2021 (+71.65 pp).
- Five-year quarterly Return on Equity [ROE] spans a low of -58.95% in Q3 2022 and a high of 68.06% in Q4 2024.
- Year over year, Return on Equity [ROE] has now declined in each of the last four quarters, with an average year-over-year change of +15.66 percentage points over the last eight quarters.
- The high point for year-over-year Return on Equity [ROE] in five years was Q4 2024 (a gain of 87.76 percentage points); the low point was Q4 2025 (a drop of 35.71 percentage points).
- Per Business Quant data, the three quarters before Q3 2026 came in at 42.32% (Q2 2026), 38.12% (Q1 2026) and 32.35% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | - |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 4.66% |
| 10 | Adma Biologics | 2.87 Bn | 2.39 Bn | 99.92 Mn | 43.09% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 43.09% |
| Jun 30, 2026 | 42.32% |
| Mar 31, 2026 | 38.12% |
| Dec 31, 2025 | 32.35% |
| Sep 30, 2025 | 50.50% |
| Jun 30, 2025 | 54.14% |
| Mar 31, 2025 | 57.24% |
| Dec 31, 2024 | 68.06% |
| Sep 30, 2024 | 32.43% |
| Jun 30, 2024 | 20.35% |
| Mar 31, 2024 | -2.52% |
| Dec 31, 2023 | -19.70% |
| Sep 30, 2023 | -15.02% |
| Jun 30, 2023 | -27.25% |
| Mar 31, 2023 | -31.73% |
| Dec 31, 2022 | -46.44% |
| Sep 30, 2022 | -58.95% |
| Jun 30, 2022 | -54.82% |
| Mar 31, 2022 | -53.14% |
| Dec 31, 2021 | -58.53% |
API Access
Adma Biologics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ADMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ADMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ADMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();